Bokf Na Trims Position in Sanofi (NASDAQ:SNY)

Bokf Na decreased its stake in shares of Sanofi (NASDAQ:SNY) by 16.6% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,529 shares of the company’s stock after selling 502 shares during the quarter. Bokf Na’s holdings in Sanofi were worth $123,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. POM Investment Strategies LLC bought a new position in shares of Sanofi during the second quarter worth $25,000. Frazier Financial Advisors LLC bought a new position in shares of Sanofi during the fourth quarter worth $28,000. Larson Financial Group LLC boosted its position in shares of Sanofi by 480.8% during the first quarter. Larson Financial Group LLC now owns 604 shares of the company’s stock worth $29,000 after acquiring an additional 500 shares during the last quarter. Register Financial Advisors LLC bought a new position in Sanofi during the first quarter valued at $29,000. Finally, Johnson Financial Group Inc. purchased a new position in shares of Sanofi in the 4th quarter worth $31,000. Institutional investors own 10.04% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on SNY shares. StockNews.com cut shares of Sanofi from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, September 11th. Argus lifted their price objective on shares of Sanofi from $55.00 to $60.00 and gave the stock a “buy” rating in a research note on Friday, July 26th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $57.50.

Sanofi Stock Performance

Shares of NASDAQ:SNY opened at $56.91 on Wednesday. The company has a market capitalization of $144.14 billion, a price-to-earnings ratio of 28.60, a PEG ratio of 1.60 and a beta of 0.60. Sanofi has a 12 month low of $42.63 and a 12 month high of $58.97. The firm’s 50-day moving average is $53.95 and its 200 day moving average is $50.30. The company has a current ratio of 1.00, a quick ratio of 0.65 and a debt-to-equity ratio of 0.17.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings results on Thursday, July 25th. The company reported $0.93 EPS for the quarter, beating the consensus estimate of $0.88 by $0.05. The company had revenue of $10.75 billion for the quarter, compared to the consensus estimate of $16.86 billion. Sanofi had a net margin of 9.60% and a return on equity of 26.29%. The firm’s revenue was up 7.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.95 EPS. Research analysts predict that Sanofi will post 4.25 EPS for the current year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.